Aprogen Biologics Inc. — Investor Relations & Filings
Filings indexed
374
across all filing types
Latest filing
2026-05-14
Interim / Quarterly Rep…
Country
KR
South Korea
Listing
KO
003060
Aprogen Biologics Inc. is a biopharmaceutical company focused on the development and manufacturing of antibody-based therapeutics. The company's activities encompass two main areas: the creation of novel biologics and the production of biosimilars. Its pipeline of new drugs includes candidates for treating conditions such as blood vessel diseases and tumors. Simultaneously, Aprogen develops a portfolio of biosimilar products to offer alternatives to existing biologic medicines. The company operates significant manufacturing facilities to support the production of its biopharmaceutical products for both clinical trials and commercial supply.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 분기보고서 (2026.03) | 2026-05-14 | Korean | |
| 주식등의대량보유상황보고서(일반) | 2026-05-08 | Korean | |
| 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-05-08 | Korean | |
| 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-05-08 | Korean | |
| 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-05-08 | Korean | |
| 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-05-08 | Korean |
Browse filings by year
9 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 45906208 | 분기보고서 (2026.03) | 2026-05-14 | Korean | ||
| 44142104 | 주식등의대량보유상황보고서(일반) | 2026-05-08 | Korean | ||
| 44141612 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-05-08 | Korean | ||
| 44131034 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-05-08 | Korean | ||
| 44130873 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-05-08 | Korean | ||
| 44130349 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-05-08 | Korean | ||
| 44130231 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-05-08 | Korean | ||
| 44130106 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-05-08 | Korean | ||
| 39050878 | 주식등의대량보유상황보고서(일반) | 2026-04-30 | Korean | ||
| 39045886 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-04-30 | Korean | ||
| 37919308 | 최대주주등소유주식변동신고서 | 2026-04-28 | Korean | ||
| 37305606 | 유상증자또는주식관련사채등의발행결과(자율공시) | 2026-04-27 | Korean | ||
| 34653551 | 최대주주등소유주식변동신고서 | 2026-04-17 | Korean | ||
| 34653473 | [기재정정]최대주주등소유주식변동신고서 | 2026-04-17 | Korean | ||
| 34646025 | 주식등의대량보유상황보고서(일반) | 2026-04-16 | Korean | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Aprogen Biologics Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/17580/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=17580 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=17580 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=17580 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 17580}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Aprogen Biologics Inc. (id: 17580)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.